EXTRAMEDULLARY PLASMACYTOMA
Clinical trials for EXTRAMEDULLARY PLASMACYTOMA explained in plain language.
Never miss a new study
Get alerted when new EXTRAMEDULLARY PLASMACYTOMA trials appear
Sign up with your email to follow new studies for EXTRAMEDULLARY PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo tackles Hard-to-Treat myeloma spread
Disease control OngoingThis study tests a combination of four drugs (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) in 41 people with multiple myeloma that has spread to organs or tissues outside the bones, like the skin or liver. The goal is to see if this treatment can shrink or contro…
Matched conditions: EXTRAMEDULLARY PLASMACYTOMA
Phase: PHASE2 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated May 17, 2026 05:07 UTC
-
New CMV strategy aims to protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or disorders. About 153 participants are involved, and the goal is to see if changing when and how anti-CMV drugs are…
Matched conditions: EXTRAMEDULLARY PLASMACYTOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC